Allantopyrone A, an α-pyrone metabolite from an endophytic fungus, inhibits the tumor necrosis factor α-induced nuclear factor κB signaling pathway

Journal of Antibiotics

Volumn 68, Issue 2, 2015, Pages 71-75

  Yokoigawa, Junpei ^a   Morimoto, Kyoko ^a   Shiono, Yoshihito ^b   Uesugi, Shota ^c   Kimura, Ken Ichi ^c   Kataoka, Takao ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c IWATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRONE DERIVATIVE; ALLANTOPYRONE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FIREFLY LUCIFERASE; I KAPPA B KINASE; PYRONE DERIVATIVE;

A549 CELL LINE; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENDOPHYTIC FUNGUS; HUMAN; HUMAN CELL; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PHOSPHORYLATION; REPORTER GENE; TUMOR CELL LINE;

FUNGI;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; I-KAPPA B KINASE; INTERCELLULAR ADHESION MOLECULE-1; LUCIFERASES, FIREFLY; LUNG NEOPLASMS; NF-KAPPA B; PHOSPHORYLATION; PYRONES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928485394     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2014.103     Document Type: Article

References (26)

1. Aggarwal, B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756 (2003).
2. Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759 (2005).
3. Hayden, M. S. & Ghosh, S. Shared principles in NF-κB signaling. Cell 132, 344-362 (2008).
4. Wajant, H. & Scheurich, P. TNFR1-induced activation of the classical NF-κB pathway. FEBS J. 278, 862-876 (2011).
5. Bhoj, V. G. & Chen, Z. J. Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437 (2009).
6. Perkins, N. D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717-6730 (2006).
7. Scheidereit, C. IkB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25, 6685-6705 (2006).
8. Ghosh, S. & Hayden, M. S. New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8, 837-848 (2008).
9. Roebuck, K. A. & Finnegan, A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66, 876-888 (1999).
10. Shiono, Y. et al. Allantopyrone A, a new a-pyrone metabolite with potent cytotoxicity from an endophytic fungus, Allantophomopsis lycopodina KS-97. J. Antibiot. 63, 251-253 (2010).
11. Kataoka, T. Chemical biology of inflammatory cytokine signaling. J. Antibiot. 62, 655-667 (2009).
12. Matsuda, I. et al. The C-terminal domain of the long form of cellular FLICE-inhibitory protein (c-FLIPL) inhibits the interaction of the caspase 8 prodomain with the receptor-interacting protein 1 (RIP1) death domain and regulates caspase-8-dependent nuclear factor kB (NF-κB) activation. J. Biol. Chem. 289, 3876-3887 (2014).
13. Takada, Y. et al. Odoroside A and ouabain inhibit Na+/K+-ATPase and prevent NF-κB-inducible protein expression by blocking Na+-dependent amino acid transport. Biochem. Pharmacol. 78, 1157-1166 (2009).
14. Yamada, Y., Tashiro, E., Taketani, S., Imoto, M. & Kataoka, T. Mycotrienin II, a translation inhibitor that prevents ICAM-1 expression induced by pro-inflammatory cytokines. J. Antibiot. 64, 361-366 (2011).
15. Dohrman, A. et al. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-κB activation. J. Immunol. 174, 5270-5278 (2005).
16. Hirano, S. & Kataoka, T. Deoxynivalenol induces ectodomain shedding of TNF receptor 1 and thereby inhibits the TNF-a-induced NF-κB signaling pathway. Eur. J. Pharmacol. 701, 144-151 (2013).
17. Tsutsui, C. et al. Peperomins as anti-inflammatory agents that inhibit the NF-κB signaling pathway. Bioorg. Med. Chem. Lett. 19, 4084-4087 (2009).
18. Tamura, R. et al. Eudesmane-type sesquiterpene lactones inhibit multiple steps in the NF-κB signaling pathway induced by inflammatory cytokines. Bioorg. Med. Chem. Lett. 22, 207-211 (2012).
19. Ogura, H. et al. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-a-mediated activation of NF-κB and caspase-8. Exp. Cell Res. 314, 1406-1414 (2008).
20. Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkB kinase. Nature 403, 103-108 (2000).
21. Straus, D. S. et al. 15-Deoxy-D12, 14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. USA 97, 4844-4849 (2000).
22. Fujimoto, Y., Tsunoda, H., Uzawa, J. & Tatsuno, T. Structure of islandic acid, a new metabolite from Penicillium islandicum Sopp. J. Chem. Soc. Chem. Commun. 1982, 83-84 (1982).
23. Fujimoto, Y. et al. Studies on the biological activities of islandic acid and related compounds. Chem. Pharm. Bull. 32, 1583-1586 (1984).
24. Kapahi, P. et al. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IkB kinase. J. Biol. Chem. 275, 36062-36066 (2000).
25. Kamiyama, H. et al. Epoxyquinol B, a naturally occurring pentaketide dimer, inhibits NF-κB signaling by crosslinking TAK1. Biosci. Biotechnol. Biochem. 72, 1894-1900 (2008).
26. Baud, V. & Karin, M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40 (2009).